ALBANY, N.Y.--(BUSINESS WIRE)--Jan. 5, 2006--Albany Molecular Research, Inc. (Nasdaq: AMRI) announced today that its Board of Directors has accelerated the vesting of stock options awarded under the company's Stock Option and Incentive Plan with an exercise price of $15.00 or greater.
